Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.
You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.
Other companies in Cytokinetics’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Ionis Pharmaceuticals (NASDAQ:IONS).
Cytokinetics has a consensus price target of $79.74.
The stock price for Cytokinetics (NASDAQ: CYTK) is $51 last updated February 21, 2025 at 5:44 PM EST.
There are no upcoming dividends for Cytokinetics.
Cytokinetics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Cytokinetics.
Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.